RECURRENT GLIOBLASTOMA IDH WILDTYPE
Clinical trials for RECURRENT GLIOBLASTOMA IDH WILDTYPE explained in plain language.
Never miss a new study
Get alerted when new RECURRENT GLIOBLASTOMA IDH WILDTYPE trials appear
Sign up with your email to follow new studies for RECURRENT GLIOBLASTOMA IDH WILDTYPE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New brain implant shows promise against deadly recurrent cancer
Disease control Not yet recruitingThis study is testing whether adding a new implant called Cerebraca Wafer to standard chemotherapy helps people with recurrent glioblastoma, a serious brain cancer, live longer. The trial will compare two groups: one receiving the wafer implant plus chemotherapy after surgery, an…
Matched conditions: RECURRENT GLIOBLASTOMA IDH WILDTYPE
Phase: PHASE2, PHASE3 • Sponsor: Everfront Biotech Co., Ltd. • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
Scientists test 'Tiny Warhead' therapy to target deadly recurrent brain tumors
Disease control Not yet recruitingThis early-stage study is testing a new two-drug combination for glioblastoma, an aggressive brain cancer that has returned after initial treatment. The first drug is a radioactive antibody designed to find and deliver radiation directly to cancer cells. The second drug is an imm…
Matched conditions: RECURRENT GLIOBLASTOMA IDH WILDTYPE
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC